#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kawasaki's disease Pituitary-dependent Cushing's syndrome Colitis ulcerative Friedreich's ataxia Hypertriglyceridaemia ROHHAD syndrome Severe myoclonic epilepsy of infancy Gastrointestinal neuroendocrine tumour Emphysema Adenovirus infection Neonatal asphyxia Vulval cancer recurrent Meningococcal immunisation Idiopathic inflammatory myopathy Thalassaemia alpha More trials…

    Learn about Rare Diseases

    Vascular malformation Mitochondrial myopathy – Treatment Sarcoma – Trials in Disease Advanced systemic mastocytosis – Treatment Netherton’s syndrome – Life with Disease Myelodysplastic syndrome Bronchiolitis obliterans syndrome Tuberous sclerosis complex – Diagnostics MELAS syndrome – Life with Disease Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Quercus Robur Pollen Extract Dersimelagon Phosphate Fosinopril Sodium Glycopyrronium Bromide Melphalan Albaconazole Elasomeran Fostemsavir Trometamol ZINC Almagate 68Ga-Nota-Abscint-Her2 M-(18F)-Fluorobenzylguanidine ULIXERTINIB Infliximab Irinotecan Hydrochloride Spiramycin Op-1250 Bisoprolol Fumarate Glepaglutide Myrrh More therapies…

    Learn about Your Condition

    Corneal dystrophy Arteriospasm coronary Dupuytren's contracture Cognitive disorder Actinic cheilitis Endometrial cancer stage II Pneumonia bacterial Vomiting Pharyngeal cancer stage III Exfoliation glaucoma Neoplasm Enteritis Retroperitoneal fibrosis Breast angiosarcoma Peritoneal abscess More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Sedation During Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis Using Remifentanil, Dexmedetomidine, and Propofol

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Remifentanil
    • Ketamine Hydrochloride
    • Propofol
    Italy

  • Study on Treating Resistant Viral Infections in Stem Cell Transplant Patients Using Allogeneic Multivirus-Specific T Cells

    Recruiting

    3 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Adenovirus infection
    • Cytomegalovirus infection
    Investigated Drugs:
    • Allogeneic Cd4+ And Cd8+ T Lymphocytes Ex Vivo Incubated With Synthetic Peptides Of The Viral Antigens Of Cytomegalovirus, Adenovirus And Epstein-Barr Virus
    Belgium France Germany Italy The Netherlands

  • Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Lenalidomide
    • Teclistamab
    Austria Belgium Czechia Denmark France Germany +7

  • Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Glucose Monohydrate Ph. Eur.
    • Levocarnitine
    • Sodium S-Lactate Solution
    Denmark Germany Italy Spain Sweden

  • Study on Naloxegol to Prevent Constipation in Patients with Brain Injury and Opioid Use

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    • Gastrointestinal motility disorder
    • Head injury
    Investigated Drugs:
    • Naloxegol Oxalate
    France

  • Study on Transmural Healing in Patients with Moderate to Severe Crohn’s Disease Using Upadacitinib and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Risankizumab
    • Adalimumab
    • Budesonide
    Belgium Denmark France Germany Italy The Netherlands +2
Previous Page
1 … 517 518 519 520 521 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!